Your browser is no longer supported. Please, upgrade your browser.
Settings
MTEM Molecular Templates, Inc. daily Stock Chart
MTEM [NASD]
Molecular Templates, Inc.
Index- P/E- EPS (ttm)-0.79 Insider Own12.75% Shs Outstand33.64M Perf Week10.52%
Market Cap208.57M Forward P/E- EPS next Y-1.25 Insider Trans0.00% Shs Float30.70M Perf Month21.81%
Income-27.20M PEG- EPS next Q-0.24 Inst Own73.50% Short Float2.34% Perf Quarter-23.08%
Sales23.90M P/S8.73 EPS this Y51.60% Inst Trans2.56% Short Ratio6.62 Perf Half Y9.35%
Book/sh2.42 P/B2.56 EPS next Y-33.00% ROA-19.30% Target Price20.20 Perf Year52.33%
Cash/sh2.15 P/C2.88 EPS next 5Y- ROE-27.70% 52W Range3.19 - 8.77 Perf YTD53.47%
Dividend- P/FCF- EPS past 5Y28.30% ROI- 52W High-29.30% Beta2.85
Dividend %- Quick Ratio3.10 Sales past 5Y1.20% Gross Margin- 52W Low94.36% ATR0.38
Employees102 Current Ratio3.10 Sales Q/Q285.70% Oper. Margin- RSI (14)60.10 Volatility8.51% 6.94%
OptionableNo Debt/Eq0.03 EPS Q/Q30.60% Profit Margin- Rel Volume0.65 Prev Close6.40
ShortableYes LT Debt/Eq0.03 EarningsAug 08 Payout- Avg Volume108.59K Price6.20
Recom1.70 SMA2016.53% SMA503.89% SMA2004.95% Volume70,740 Change-3.13%
Apr-29-19Initiated UBS Buy $12
Dec-11-18Initiated Oppenheimer Outperform $15
Oct-08-18Initiated Laidlaw Buy $18
Aug-29-19 07:30AM  Is Molecular Templates (NASDAQ:MTEM) Using Too Much Debt? Simply Wall St.
Aug-12-19 04:30PM  Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results GlobeNewswire
Aug-01-19 10:33AM  Analysts Estimate Molecular Templates (MTEM) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-10-19 03:27PM  Molecular Templates (NASDAQ:MTEM) Shareholders Have Enjoyed A 52% Share Price Gain Simply Wall St.
Jun-29-19 07:19PM  Did Hedge Funds Drop The Ball On Molecular Templates, Inc. (MTEM) ? Insider Monkey
Jun-17-19 08:00AM  Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38 GlobeNewswire +5.33%
May-29-19 05:26AM  Will Molecular Templates to Surge Higher? Zacks
May-14-19 04:30PM  Molecular Templates to Present at the Oppenheimer New York Oncology Insight Summit and the UBS Global Healthcare Conference GlobeNewswire
May-13-19 04:01PM  Molecular Templates, Inc. Reports First Quarter 2019 Financial Results GlobeNewswire -6.70%
May-06-19 10:30AM  Will Molecular Templates (MTEM) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-25-19 10:12AM  The Judge Group Named a Winner of the Delaware Valley 2019 Top Workplaces Award by Philadelphia Media Network GlobeNewswire
Apr-22-19 08:00AM  Molecular Templates Announces FDA Acceptance of IND Application for MT-5111, An Engineered Toxin Body Targeting HER2 GlobeNewswire
Apr-04-19 09:57AM  The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy Zacks +7.80%
Apr-03-19 09:16AM  Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy Zacks
08:09AM  Will Molecular Templates Continue to Surge Higher? Zacks
Apr-02-19 07:00AM  Molecular Templates Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2019 Highlight Evolution of ETB Platform GlobeNewswire +6.35%
Mar-28-19 04:30PM  Molecular Templates, Inc. Reports Fourth Quarter 2018 Financial Results GlobeNewswire
08:00AM  Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients GlobeNewswire
Mar-05-19 04:30PM  Molecular Templates to Present a Corporate Overview at the Cowen & Company 39th Annual and the Oppenheimer & Co. 29th Annual Health Care Conferences GlobeNewswire +10.32%
Feb-27-19 05:00PM  New Data on Molecular Templates Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019 GlobeNewswire -5.73%
Feb-19-19 04:30PM  Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer GlobeNewswire
Feb-12-19 08:30AM  New Research Coverage Highlights Overstock, Regeneron Pharmaceuticals, Molecular Templates, The Ensign Group, Limoneira, and Primo Water Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-18-19 12:00PM  Do Institutions Own Molecular Templates, Inc. (NASDAQ:MTEM) Shares? Simply Wall St. -5.59%
Nov-26-18 04:30PM  Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences GlobeNewswire
Nov-13-18 04:30PM  Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Nov-09-18 08:00AM  Study on Molecular Templates PD-L1 ETB with Antigen Seeding Technology Presented at SITC Annual Meeting GlobeNewswire -9.47%
Oct-16-18 07:35AM  New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular Templates, and Aevi Genomic Medicine Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-28-18 05:00AM  4 Beaten-Up Biotech Stocks Big Investors Are Buying Now Barrons.com
Sep-26-18 08:00AM  Molecular Templates to Present at the Ladenburg Thalmann and Cantor Healthcare Conferences GlobeNewswire
Sep-25-18 04:30PM  Molecular Templates, Inc. Announces Closing of Public Offering of Common Stock and the Full Exercise of the Underwriters Option to Purchase Additional Shares GlobeNewswire -5.27%
Sep-20-18 08:41PM  Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire -7.36%
11:40AM  Molecular Templates Surges 50%, Inks Cancer Deal With Takeda Zacks
09:02AM  The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut Benzinga
08:00AM  Todays Research Reports on Stocks to Watch: Molecular Templates and Altimmune ACCESSWIRE
Sep-19-18 04:01PM  Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire +52.44%
11:37AM  Development Deal With Takeda Pharma Sends Molecular Templates Shares Rocketing Higher Benzinga
08:15AM  Molecular Templates' stock soars after development deal with Takeda MarketWatch
08:00AM  Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy GlobeNewswire
Aug-16-18 07:40AM  Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biotherapeutics, Forward Industries, Apollo Endosurgery, and Myomo Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-09-18 04:30PM  Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results GlobeNewswire
Jun-21-18 04:30PM  Molecular Templates Set to Join the Russell 3000® and Russell Microcap® Indexes GlobeNewswire
Jun-04-18 04:30PM  Molecular Templates Presents Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 GlobeNewswire
05:35AM  Moving Average Crossover Alert: Molecular Templates Inc. (MTEM) Zacks
May-31-18 04:05PM  Molecular Templates to Present at the Jefferies Global Healthcare Conference GlobeNewswire -7.75%
May-23-18 08:15AM  Report: Exploring Fundamental Drivers Behind Tenneco, RadNet, Data I/O, Icahn Enterprises, PBF Logistics LP, and Molecular Templates New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
May-16-18 05:00PM  Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 GlobeNewswire
May-15-18 04:30PM  Molecular Templates to Present at the UBS Global Healthcare Conference GlobeNewswire -8.02%
May-14-18 04:30PM  Molecular Templates, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
Apr-27-18 12:50PM  With A -91.25% Earnings Drop, Did Molecular Templates Inc (NASDAQ:MTEM) Really Underperform? Simply Wall St. +6.97%
Mar-30-18 08:25AM  Consolidated Research: 2018 Summary Expectations for RadNet, Molecular Templates, Federated Investors, Kadant, Heartland Financial, and Calyxt Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-28-18 04:30PM  Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results GlobeNewswire
Mar-19-18 04:01PM  Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference GlobeNewswire
Mar-15-18 08:00AM  New Data on Molecular Templates Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2018 GlobeNewswire
Mar-08-18 08:00AM  Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-02-18 04:30PM  Molecular Templates Closes $10 Million Debt Facility with Perceptive Advisors GlobeNewswire
Jan-30-18 07:45AM  New Research: Key Drivers of Growth for Fidus Investment, Athenex, Threshold Pharmaceuticals, Cintas, GNC, and Hillenbrand Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-05-18 08:00AM  Molecular Templates Provides Corporate Update and Outlines 2018 Milestones GlobeNewswire +10.86%
Dec-19-17 01:55PM  Did Molecular Templates Inc (NASDAQ:MTEM) Create Value For Shareholders? Simply Wall St. +9.10%
Nov-21-17 04:01PM  Molecular Templates to Present at the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-14-17 04:15PM  Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer GlobeNewswire
04:01PM  Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results GlobeNewswire
Oct-24-17 08:52AM  Molecular Templates Announces Dosing of First Patient in Phase 1 Expansion Study of MT-3724 in Diffuse Large B-Cell Lymphoma (DLBCL) GlobeNewswire
Oct-06-17 08:00AM  Molecular Templates to Present at the 2017 BIO Investor Forum GlobeNewswire +16.26%
Sep-22-17 01:54PM  Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences GlobeNewswire
Sep-06-17 02:17PM  Molecular Templates to Present at the BioCentury 24th Annual Newsmakers in the Biotech Industry Conference GlobeNewswire
Sep-05-17 12:41PM  5 of the Best Stocks Under $10 for 2017 Zacks
Aug-31-17 10:10AM  Molecular Templates, Inc. (Nasdaq: MTEM) to Ring the Nasdaq Stock Market Closing Bell GlobeNewswire
Aug-30-17 08:30AM  Molecular Templates to Ring NASDAQ Closing Bell Friday, September 1, 2017 GlobeNewswire
Aug-14-17 08:00AM  Molecular Templates to Present at the 2017 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-10-17 08:00AM  Molecular Templates Potential Catalysts, Merger Synergies and Pipeline Review ACCESSWIRE
Molecular Templates, Inc., a clinical stage oncology company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. The company primarily develops a pipeline of engineered toxin bodies. Its lead drug candidate is MT-3724 that is in a Phase II clinical trial for the treatment of relapsed/refractory diffuse large B-cell lymphoma; and Phase II clinical trial for treating non-Hodgkin's lymphoma. The company also develops MT-4019, engineered toxin body targeting CD38; and TAK-169 targeting CD38. It has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma. Molecular Templates, Inc. is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CDK ASSOCIATES, L.L.C.DirectorDec 26Buy3.4525,00086,2501,584,241Dec 28 05:30 PM
Poma Eric ESee RemarksNov 26Option Exercise0.53239,896125,972239,896Nov 29 05:34 PM
Morenstein Scott DDirectorSep 25Buy5.50545,4542,999,9971,559,241Sep 27 03:11 PM
Longitude Capital Partners III10% OwnerSep 21Buy5.50365,0002,007,5003,261,535Sep 25 04:43 PM
Hirsch DavidDirectorSep 21Buy5.50365,0002,007,5003,261,535Sep 25 04:18 PM